Marinomed Biotech AG (MARI) Stock Price & News

All values in EUR	Mrt. 2025	Jun. 2025	Sep. 2025	Des. 2025
Revenue	6,50 m	918,87 k	270,60 k	270,60 k
Cost of goods sold	-	1,29 m	64,77 k	64,77 k
Cost of revenue	-	1,29 m	64,77 k	64,77 k
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	-	2,19 m	905,56 k	905,56 k
Operating expense	-15,70 m	19,78 m	1,36 m	1,36 m
Total operating expenses	-15,70 m	21,07 m	1,43 m	1,43 m
Operating income	22,20 m	-20,15 m	-1,16 m	-1,16 m
Other non operating income	-	10,02 k	4,53 k	4,53 k
EBT including unusual items	22,20 m	-1,50 m	-1,29 m	-1,29 m
EBT excluding unusual items	22,20 m	-20,41 m	-1,29 m	-1,29 m
Income tax expense	100,00 k	-117,13 k	61,62 k	61,62 k
Effective tax rate	0,45%	7,83%	-4,78%	-4,78%
Other operating expenses	-15,70 m	17,42 m	382,00 k	382,00 k
Net income	22,10 m	-1,38 m	-1,35 m	-1,35 m
Net profit margin	340,00%	-150,15%	-499,28%	-499,28%
Earnings per share	-	-	-	-
Interest and investment income	-	-	-	-
Interest expense	-	-270,32 k	-136,49 k	-136,49 k
Net interest expenses	-	-270,32 k	-136,49 k	-136,49 k
Depreciation and amortization charges	-	160,49 k	75,70 k	75,70 k
EBITDA	22,30 m	-20,07 m	-1,08 m	-1,08 m
Gain or loss from assets sale	-	-	-	-

Finance